The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Addressing overtreatment of screen detected DCIS; the LORIS trial
Open accessAbstract
Overdiagnosis, and thus overtreatment, are inevitable consequences of most screening programmes; identification of ways of minimising the impact of overdiagnosis demands new prospective research, in particular the need to separate clinically relevant lesions that require active treatment from those that can be safely left alone or monitored and only need treated if they change characteristics. Breast cancer screening has led to a large increase in ductal carcinoma in situ (DCIS) diagnoses. This is a widely heterogeneous disease and most DCIS detected through screening is of high cytonuclear grade and therefore likely to be important clinically. However, the historic practice of surgical treatment for all DCIS is unlikely to be optimal for lower risk patients. A clearer understanding of how to manage DCIS is required. This article describes the background and development of 'The low risk' DCIS trial (LORIS), a phase III trial of surgery versus active monitoring. LORIS will determine if it is appropriate to manage women with screen detected or asymptomatic, low grade and intermediate grade DCIS with low grade features, by active monitoring rather than by surgical treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
You want to measure coping but your protocol’ too long: Consider the brief cope
Carver, C. S. (1997) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0401_6 · Cited by 7,361
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Solin, L. J., Gray, R., Baehner, F. L., Butler, S. M., Hughes, L. L., Yoshizawa, C., Cherbavaz, D. B., Shak, S., Page, D. L., Sledge, G. W., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt067 · Cited by 518
Sanders, M. E., Schuyler, P. A., Dupont, W. D., & Page, D. L. (2005) · Cancer · doi:10.1002/cncr.21069 · Cited by 485
The molecular pathology of breast cancer progression
Bombonati, A., & Sgroi, D. C. (2011) · The Journal of Pathology · doi:10.1002/path.2808 · Cited by 455
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Kerlikowske, K., Molinaro, A. M., Gauthier, M. L., Berman, H. K., Waldman, F., Bennington, J., Sanchez, H., Jimenez, C., Stewart, K., Chew, K., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq101 · Cited by 343
Long-term follow-up of in situ carcinoma of the breast.
Eusebi, V., Feudale, E. A. A., Foschini, M. P., Micheli, A., Conti, A., Riva, C., Palma, S. D., & Rilke, F. O. (1994) · PubMed · Cited by 294
Wade, J., Donovan, J. L., Athene Lane, J., Neal, D. E., & Hamdy, F. C. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.02.023 · Cited by 207
Donovan, J., Lane, J. A., Peters, T. J., Brindle, L. A., Salter, E., Gillatt, D. A., Powell, P. H., Bollina, P. R., Neal, D. E., & Hamdy, F. C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.02.010 · Cited by 159
Mammographic Screening and “Overdiagnosis”
Kopans, D. B., Smith, R. A., & Duffy, S. W. (2011) · Radiology · doi:10.1148/radiol.11110716 · Cited by 95
Yu, Y., Liang, C. D., & Yuan, X.-Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0750-1 · Cited by 88
Steinman, S., Wang, J., Bourne, P. A., Yang, Q., & Tang, P. (2007) · PubMed · Cited by 82
Iakovlev, V. V., Arneson, N. C. R., Wong, V., Wang, C., Leung, S., Iakovleva, G., Warren, K., Pintilie, M., & Done, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4960 · Cited by 53
Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays
Kearney, A., McKay, A., Hickey, H., Balabanova, S., Marson, A. G., Gamble, C. L., & Williamson, P. R. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005874 · Cited by 28
Time for a low-risk DCIS trial: harnessing public and patient involvement
Fallowfield, L. J., Francis, A., Catt, S., MacKenzie, M., & Jenkins, V. A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70503-x · Cited by 24
Self-citationOpening research sites in multicentre clinical trials within the UK: a detailed analysis of delays
Williamson, P. R., Gamble, C. L., Kearney, A., & Hickey, H. (2013) · Trials · doi:10.1186/1745-6215-14-s1-o59 · Cited by 5
Cited by
Dietz, J. R., Moran, M. S., Isakoff, S. J., Kurtzman, S. H., Willey, S. C., Burstein, H. J., Bleicher, R. J., Lyons, J. A., Sarantou, T., Baron, P. L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05644-z · Cited by 393
Ductal carcinoma in situ: to treat or not to treat, that is the question
on behalf of the PRECISION team, van Seijen, M., Lips, E. H., Thompson, A. M., Nik-Zainal, S., Futreal, A., Hwang, E. S., Verschuur, E., Lane, J., Jonkers, J., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0478-6 · Cited by 320
Self-citation
Metadata
- Authors
- Francis, A., Thomas, J., Fallowfield, L., Wallis, M., Bartlett, J. M. S., Brookes, C., Roberts, T., Pirrie, S., Gaunt, C., Young, J., Billingham, L., Dodwell, D., Hanby, A., Pinder, S. E., Evans, A., Reed, M., Jenkins, V., Matthews, L., Wilcox, M., Fairbrother, P., Bowden, S., & Rea, D.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 51
- Issue
- 16
- Pages
- 2296-2303
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2119349383
- Cited by
- 376
- References
- 16
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.